Anirban Maitra: $200 Million Target for Advancing Cancer Vaccines
Anirban Maitra/LinkedIn

Anirban Maitra: $200 Million Target for Advancing Cancer Vaccines

Anirban Maitra, Director of the Perlmutter Cancer Center, shared a post on X:

“Hoping to hit a $200 million target, National Cancer Institute and Foundation for the National Institutes of Health develop a plan for advancing cancer vaccines.

Details on how this ambitious public private agenda will be put in place. From The Cancer Letter.

Anirban Maitra: $200 Million Target for Advancing Cancer Vaccines

Other articles featuring Anirban Maitra on OncoDaily.